APA (7th ed.) Citation

GP, F., DJ, D., G, A., EG, W., C, B., LM, H., . . . JL, S. (2024). Real-World Evidence of Omnipod® 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 Diabetes. Diabetes technology & therapeutics, 26(8), 514. https://doi.org/10.1089/dia.2023.0578

Chicago Style (17th ed.) Citation

GP, Forlenza, et al. "Real-World Evidence of Omnipod® 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 Diabetes." Diabetes Technology & Therapeutics 26, no. 8 (2024): 514. https://doi.org/10.1089/dia.2023.0578.

MLA (9th ed.) Citation

GP, Forlenza, et al. "Real-World Evidence of Omnipod® 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 Diabetes." Diabetes Technology & Therapeutics, vol. 26, no. 8, 2024, p. 514, https://doi.org/10.1089/dia.2023.0578.